Exom BioPharma has isolated a novel exosome from FDA approved food source (named as Q5 EXOSOMES) which has several technological advantages over stem cells and bovine milk derived exosomes.
Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and preclinical (drug delivery) applications. Our company is also actively engaged in targeted exosome delivery research using our proprietary Q5 Exosome technology and identifying biomarkers for the early diagnosis of Pancreatic & Head and Neck Cancer and cardiovascular disease.
Our company is also working towards procuring patient related biospecimen (blood, urine, saliva, CSF) and isolating cfDNA and exosomes for biomarker discovery. We are looking for R&D collaborations with research institutions and pharmaceutical companies for our Q5 Exosomes.
Company Details
- Founded
- -
- Address
- 910 Clopper Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.exombiopharma.com/
- Keywords
- Exosome Isolation, Purified Exosomes, Q5 exosomes, Exosomes Storage, Exosome Immuno, Exosome Essentials, Antibodies, Biosynthesis, Monoclonal Antibodies, miRNA, Protein Isolaition.
- HQ
- Gaithersburg, Maryland
Exom Biopharma, Inc. Questions
Exom Biopharma, Inc.'s website is https://www.exombiopharma.com/
Exom Biopharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/exom-biopharma-inc
Exom Biopharma, Inc.'s industry is
Biotechnology Research
Exom Biopharma, Inc.'s top competitors are
Pharma Logic International,
K2 Group, Llc,
Ebz Consulting,
Htec,
Financial Leadership Association At Ut Dallas,
Empire Rx Inc,
Drink The Air,
Exom Biopharma,
Electrify Payments,
American Generics.
Exom Biopharma, Inc.'s categories are Biotechnology Research
Exom Biopharma, Inc.'s founding year is 2022
